CTC1 mutations in a Brazilian family with progeroid features and recurrent bone fractures. Issue 6 (4th November 2018)

• Record Type: Journal Article
• Authors: Sargolzaeiaval, Forough; Zhang, Jiaming; Schleit, Jennifer; Lessel, Davor; Kubisch, Christian; Precioso, Debora R.; Sillence, David; Hisama, Fuki M.; Dorschner, Michael; Martin, George M.; Oshima, Junko
• Is Part Of: Molecular genetics & genomic medicine. Volume 6:Issue 6(2018)
• Page Start: 1148
• Page End: 1156
• Publication Date: 2018-11-04
• Subjects: CTC1 -- genomic instability -- Mendelian disorders -- molecular genetics -- progeroid syndrome -- telomeres; Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.495
• Languages: English
• ISSNs: 2324-9269

Abstract

Abstract: Background: Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) is an autosomal recessive disorder caused by pathogenic variants of the conserved telomere maintenance component 1 ( CTC1 ) gene. The CTC1 forms the telomeric capping complex, CST, which functions in telomere homeostasis and replication. Methods: A Brazilian pedigree and an Australian pedigree were referred to the International Registry of Werner Syndrome (Seattle, WA, USA), with clinical features of accelerated aging and recurrent bone fractures. Whole exome sequencing was performed to identify the genetic causes. Results: Whole exome sequencing of the Brazilian pedigree revealed compound heterozygous pathogenic variants in CTC1 : a missense mutation (c.2959C>T, p.Arg987Trp) and a novel stop codon change (c.322C>T, p.Arg108*). The Australian patient carried two novel heterozygous CTC1 variants, c.2916G>T, p.Val972Gly and c.2926G>T, p.Val976Phe within the same allele. Both heterozygous variants were inherited from the unaffected father, excluding the diagnosis of CRMCC in this pedigree. Cell biological studies demonstrated accumulation of double strand break foci in lymphoblastoid cell lines derived from the patients. Increased DSB foci were extended to non‐telomeric regions of the genome, in agreement with previous biochemical studies showing a preferential binding of CTC1 protein to GC‐rich sequences. Conclusion: CTC1 pathogenic variants can present with unusual manifestations of progeria accompanied with recurrent bone fractures. Further studies are needed to elucidate the disease mechanism leading to the clinical presentation with intra‐familial variations of CRMCC. Abstract : Novel CTC1 mutations were identified in patients referred to the international registry of Werner syndrome, presenting features of progeria and recurrent bone fractures. Increased number of DNA damage foci was detected in CTC1 mutants which were extended to whole genome.